Executive Summary - The Drug Enforcement Administration (DEA) issued a temporary rule (Temporary Rule), effective 11 May 2023, extending flexibilities regarding the prescribing of controlled substances via telemedicine that...more
This week’s episode is the second in an ongoing series focusing on recent efforts by the Substance Abuse and Mental Health Services Administration (SAMHSA) to update 42 C.F.R. Part 2 (Part 2) regulations related to the...more
10/17/2019
/ Confidential Information ,
Consent ,
Health Care Providers ,
Healthcare Facilities ,
Medical Records ,
Mental Health ,
Opioid ,
Patient Privacy Rights ,
Pharmaceutical Industry ,
Pharmacies ,
Podcasts ,
Prescription Drugs ,
Proposed Rules ,
SAMHSA ,
Substance Abuse
This episode is the first in a series focusing on recent efforts by the Substance Abuse and Mental Health Services Administration (SAMHSA) to update 42 C.F.R. Part 2 (Part 2) regulations related to the confidentiality of...more
10/8/2019
/ Confidential Information ,
Data Privacy ,
Data Use Policies ,
Electronic Medical Records ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Manufacturer Liability ,
Medical Records ,
Mental Health ,
Multidistrict Litigation ,
Municipalities ,
Opioid ,
Patient Privacy Rights ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Proposed Rules ,
Regulatory Agenda ,
SAMHSA ,
Substance Abuse
On August 28, 2015, the Health Resources and Services Administration (“HRSA”) published proposed Omnibus Guidance (the “Proposed Guidance”) governing policies related to section 340B of the Public Health Service Act (“PHSA”),...more
9/8/2015
/ Affordable Care Act ,
AIDS ,
Compliance ,
Covered Entities ,
Drug Pricing ,
Fee-for-Service ,
Food and Drug Administration (FDA) ,
GPOs ,
Health Care Providers ,
Healthcare ,
HIV ,
Hospitals ,
HRSA ,
MCOs ,
Medicaid ,
Medicare ,
Omnibus Guidance ,
Pharmaceutical Industry ,
Pharmacies ,
PHSA ,
Prescription Drugs ,
Section 340B ,
Telemedicine